Last year, the Patented Medicine Prices Review Board stalled the implementation of new guidelines that would govern changes intended to lower the cost of patented drugs in Canada.
Researchers report that despite significant investments to transform the struggling primary care system, Canada lags behind most high-income countries in key areas
Dr. Jeffrey Wilkinson of the South Saskatchewan Heart Clinic in Moose Jaw says it's too operationally and financially difficult to keep running under the public system.
